Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense oligonucleotide drug design.

N Schiavone1, M Donnini, A Nicolin

  • 1Department of Experimental Pathology and Oncology, University of Florence, Viale G.B. Morgagni 50, 50134-Florence, Italy. nicola.schiavone@unifi.it

Current Pharmaceutical Design
|March 23, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The caged dynamics, the Johari-Goldstein β relaxation, and the structural α-relaxation and their interconnections in amorphous waters.

The Journal of chemical physics·2026
Same author

Thermal Stability of Organic Semiconductor Thin Film Glasses by Local Changes in Spontaneous Orientation Polarization.

The journal of physical chemistry. B·2025
Same author

Inventory of landslides triggered by an extreme rainfall event in Marche-Umbria, Italy, on 15 September 2022.

Scientific data·2023
Same author

Arriving at the most plausible interpretation of the dielectric spectra of glycerol with help from quasielastic γ-ray scattering time-domain interferometry.

Physical review. E·2022
Same author

Intermittent-contact local dielectric spectroscopy of nanostructured interfaces.

Nanotechnology·2022
Same author

Tuning-fork-based piezoresponse force microscopy.

Nanotechnology·2021
Same journal

Role of Phenolic Nanocompounds in Inflammatory Disorders: Current View and Future Aspects.

Current pharmaceutical design·2026
Same journal

Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.

Current pharmaceutical design·2026
Same journal

Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.

Current pharmaceutical design·2026
Same journal

Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.

Current pharmaceutical design·2026
Same journal

Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.

Current pharmaceutical design·2026
Same journal

Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.

Current pharmaceutical design·2026
See all related articles

Modulating gene expression offers new disease treatments. The antisense strategy, using synthetic nucleic acid segments, provides a flexible, cost-effective method for gene silencing, advancing therapeutic development.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • Gene expression modulation is key to understanding gene function and treating genetic diseases.
  • Genome projects have yielded high-throughput techniques for analyzing complex molecular networks.
  • Combining gene expression modulation with new technologies aids in unraveling molecular pathways.

Purpose of the Study:

  • To review recent advancements in antisense-based gene expression modulation.
  • To explore the therapeutic potential of antisense strategies for treating diseases.
  • To analyze the historical context and future prospects of antisense therapeutics.

Main Methods:

  • Gene targeting via transgenic or knockout organisms/cells.
  • mRNA targeting using synthetic antisense oligonucleotides.

Related Experiment Videos

  • RNA interference (RNAi) as a natural gene silencing mechanism.

    • Main Results:

    • The antisense strategy offers flexibility, safety, specificity, reversibility, and cost-effectiveness compared to genome manipulation.
    • Antisense oligonucleotides can silence gene expression by targeting specific mRNAs.
    • RNA interference enhances the 'informational' strategy for gene silencing.

    Conclusions:

    • Antisense-based gene expression modulation shows significant promise for disease treatment.
    • Despite advancements, antisense therapeutics are still under development and not yet a clinical reality.
    • Further research and development are needed to fully realize the potential of antisense strategies in medicine.